OpenArc Corporate Advisory’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52M Sell
42,950
-11,348
-21% -$1.33M 0.07% 151
2026
Q1
$6.53M Buy
54,298
+9,610
+22% +$1.11M 0.09% 132
2025
Q4
$4.7M Buy
+44,688
New +$4.19M 0.08% 144

Other funds holding MRK

OpenArc Corporate Advisory's MRK Position: Q2 2026 in Review

OpenArc Corporate Advisory reduced its Merck (MRK) stake by 21% in Q2 2026, selling an estimated $1.33M and leaving 42,950 shares worth $5.52M. The position accounts for 0.07% of the portfolio, ranked #151.

OpenArc Corporate Advisory first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.53M in Q1 2026. 2,270 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • OpenArc Corporate Advisory held 42,950 shares of Merck worth $5.52M as of Q2 2026.
  • OpenArc Corporate Advisory sold 11,348 Merck shares in Q2 2026, an estimated $1.33M.
  • Merck made up 0.07% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #151 holding.
  • OpenArc Corporate Advisory first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • OpenArc Corporate Advisory's Merck position peaked at $6.53M in Q1 2026.
  • 2,270 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.